Growth Factor Receptor Signaling and Metastasis of Oral Cancer

  • Ali Razfar
  • Jennifer R. Grandis


Growth factor receptor signaling activates a number of pathways involved in cellular proliferation and survival. Overexpression and activation of various growth factor receptors have been implicated in a number of cancers. The progression of tumor cells to an invasive phenotype requires a number of important steps, including the loss of cellular adhesion complexes and the migration of tumor cells to distant sites. These steps are regulated by growth factor receptors such as epidermal growth factor receptor (EGFR) and c-Met leading to metastasis. Overexpression and activation of EGFR lead to loss of intercellular adhesions through the downregulation of E-cadherins, desmosomes, and focal adhesion kinase. Furthermore, EGFR signaling can upregulate matrix metalloproteases (MMPs), leading to the degradation of the extracellular matrix and increased motility. Hepatocyte growth factor (HGF)/c-Met signaling can also disrupt E-cadherin expression and upregulate MMP expression, resulting in a more invasive phenotype. Thus, growth factor receptors play a major role in tumor metastasis through the regulation of key intermediary steps.


Epidermal Growth Factor Receptor Hepatocyte Growth Factor Focal Adhesion Kinase Epidermal Growth Factor Receptor Expression Epidermal Growth Factor Receptor Inhibition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL (1991) Elevated Content of the Tyrosine Kinase Substrate Phospholipase C-1 in Primary Human Breast Carcinomas. Proc Am Assoc Cancer Res 88:10435–10439Google Scholar
  2. Bankfalvi A, Krassort M et al (2002) Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression. J Pathol 198:343–351CrossRefPubMedGoogle Scholar
  3. Bennett JH, Morgan MJ et al (2000) Metalloproteinase expression in normal and malignant oral keratinocytes: stimulation of MMP-2 and -9 by scatter factor. Eur J Oral Sci 108:281–291CrossRefPubMedGoogle Scholar
  4. Chidgey M, Dawson C (2007) Desmosomes: a role in cancer? Br J Cancer 96:1783–1787CrossRefPubMedGoogle Scholar
  5. Chou JD, Stolz B et al (2002) Distribution of gelsolin and phosphoinositol 4, 5-bisphosphate in lamellipodia during EGF-induced motility. Int J Biochem Cell Biol 34:776–790CrossRefPubMedGoogle Scholar
  6. Christensen ME, Therkildsen MH et al (1993) Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J Pathol 169:323–328CrossRefPubMedGoogle Scholar
  7. Cooper JS, Pajak TF et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944CrossRefPubMedGoogle Scholar
  8. Endo K, Shirai A et al (2006) Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum Pathol 37(8):1111–1116CrossRefPubMedGoogle Scholar
  9. Fridman JS, Caulder E et al (2007) Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin Cancer Res 13(6):1892–1902CrossRefPubMedGoogle Scholar
  10. Ghosh S, Munshi HG et al (2002) Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma. Cancer 95(12):2524–2533CrossRefPubMedGoogle Scholar
  11. Grandis JR, Chakraborty A et al (1998) Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. J Cell Biochem 69:55–62CrossRefPubMedGoogle Scholar
  12. Grille SJ, Bellacosa A et al (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63(9):2172–2178PubMedGoogle Scholar
  13. Grotegut S, von Schweinitz D et al (2006) Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25(15):3534–3545CrossRefPubMedGoogle Scholar
  14. Hanzawa M, Shindoh M et al (2000) Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21(6):1079–1085CrossRefPubMedGoogle Scholar
  15. Hazan RB, Norton L (1998) The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 273(15):9078–9084CrossRefPubMedGoogle Scholar
  16. Higashino F, Yoshida K et al (1995) Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10(7):1461–1463PubMedGoogle Scholar
  17. Hiraishi Y, Wada T et al (2006) Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res 12:87–91CrossRefPubMedGoogle Scholar
  18. Hiscox S, Morgan L et al (2006) Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells. Breast Cancer Res Treat 97:263–274CrossRefPubMedGoogle Scholar
  19. Hong SD, Hong SP et al (2000) Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36(2):207–213CrossRefPubMedGoogle Scholar
  20. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5:341–354CrossRefPubMedGoogle Scholar
  21. Kim CH, Moon SK et al (2006) Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol 126(1):88–94CrossRefPubMedGoogle Scholar
  22. Kornberg LJ (1998) Focal adhesion kinase expression in oral cancers. Head Neck 20(7):634–639CrossRefPubMedGoogle Scholar
  23. Kusukawa J, Harada H et al (1996) The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol 32B(4):217–221CrossRefPubMedGoogle Scholar
  24. Lee CK, Raz R et al (2002) STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17(1):63–72CrossRefPubMedGoogle Scholar
  25. Lee CW, Lin CC et al (2007a) TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 292(3):L799–L812CrossRefPubMedGoogle Scholar
  26. Lee EJ, Whang JH et al (2007b) The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism. Ann N Y Acad Sci 1095:113–128CrossRefPubMedGoogle Scholar
  27. Lim J, Kim JH et al (2005) Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol 58(11):1199–1205CrossRefPubMedGoogle Scholar
  28. Lin CS, Jen YM et al (2006) Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck 28(2):150–157CrossRefPubMedGoogle Scholar
  29. Lorimer IA (2002) Mutant epidermal growth factor receptors as targets for cancer therapy. Curr Cancer Drug Targets 2:91–102CrossRefPubMedGoogle Scholar
  30. Lu Z, Ghosh S et al (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4(6):499–515CrossRefPubMedGoogle Scholar
  31. Lynch TJ Jr, Kim ES et al (2007) Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 12(5):610–621CrossRefPubMedGoogle Scholar
  32. Margulis A, Zhang W et al (2005) E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Cancer Res 65(5):1783–1791CrossRefPubMedGoogle Scholar
  33. Matsumoto K, Matsumoto K et al (1994) Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269(50):31807–31813PubMedGoogle Scholar
  34. Morello S, Olivero M et al (2001) MET receptor is overexpressed but not mutated in oral squamous cell carcinomas. J Cell Physiol 189(3):285–290CrossRefPubMedGoogle Scholar
  35. Murai M, Shen X et al (2004) Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. Int J Oncol 25(4):831–840PubMedGoogle Scholar
  36. Owens LV, Xu L et al (1995) Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55(13):2752–2755PubMedGoogle Scholar
  37. O-Charoenrat PH, Modjtahedi H et al (2000a) Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 60(4):1121–1128PubMedGoogle Scholar
  38. O-Charoenrat P Rhys-Evans et al (2000b) Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86(3):307–317CrossRefPubMedGoogle Scholar
  39. Papagerakis S, Shabana AH et al (2004) Altered plakoglobin expression at mRNA and protein levels correlates with clinical outcome in patients with oropharynx squamous carcinomas. Hum Pathol 35(1):75–85CrossRefPubMedGoogle Scholar
  40. Patel BP, Shah PM et al (2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90(2):81–88CrossRefPubMedGoogle Scholar
  41. Perez-Moreno M, Jamora C et al (2003) Sticky business: orchestrating cellular signals at adherens junctions. Cell 112(4):535–548CrossRefPubMedGoogle Scholar
  42. Peruzzi B, Bottaro DP (2006) Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12(12):3657–3660CrossRefPubMedGoogle Scholar
  43. Schneider GB, Kurago Z et al (2002) Elevated focal adhesion kinase expression facilitates oral tumor cell invasion. Cancer 95(12):2508–2515CrossRefPubMedGoogle Scholar
  44. Schwarz J, Ayim A et al (2006) Differential expression of desmosomal plakophilins in various types of carcinomas: correlation with cell type and differentiation. Hum Pathol 37(5):613–622CrossRefPubMedGoogle Scholar
  45. Shintani S, Li C et al (2003) Gefitinib (“Iressa”), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells. Cancer Lett 201(2):149–155CrossRefPubMedGoogle Scholar
  46. Sobolik-Delmaire T, Katafiasz D et al (2007) Decreased plakophilin-1 expression promotes increased motility in head and neck squamous cell carcinoma cells. Cell Commun Adhes 14(2):99–109CrossRefPubMedGoogle Scholar
  47. Sok JC, Coppelli FM et al (2006) Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res 12(17):5064–5073CrossRefPubMedGoogle Scholar
  48. Tanaka M, Kitajima Y et al (2002) Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg 89(2):236–244PubMedGoogle Scholar
  49. Tanaka N, Odajima T et al (2003) Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89(3):557–563CrossRefPubMedGoogle Scholar
  50. Thomas SM, Coppelli FM et al (2003) Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res 63(17):5629–5635PubMedGoogle Scholar
  51. Todd R, Donoff BR et al (1989) TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 10(8):1553–1556CrossRefPubMedGoogle Scholar
  52. Tsai ST, Yang KY et al (2006) Amphiregulin as a tumor promoter for oral squamous cell carcinoma: involvement of cyclooxygenase 2. Oral Oncol 42:381–390CrossRefPubMedGoogle Scholar
  53. Uchida D, Kawamata H et al (2001) Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 93(4):489–496CrossRefPubMedGoogle Scholar
  54. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137CrossRefPubMedGoogle Scholar
  55. Yin T, Green KJ (2004) Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 15(6):665–677PubMedGoogle Scholar
  56. Zhang Q, Bhola NE et al (2007) Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer. Mol Cancer Ther 6(4):1414–1424CrossRefPubMedGoogle Scholar
  57. Zhang X, Liu Y et al (2002) A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95(8):1663–1672CrossRefPubMedGoogle Scholar
  58. Zhao XJ, Li H et al (2003) Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol 9(2):225–232PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.The Eye and Ear InstitutePittsburghUSA

Personalised recommendations